More Videos
- Eli Lilly's Ladies' Drug Campaign: Kind of Strange TV Ad?
- Reporters Barred from Ariad, Celgene, Cougar Roundtable?
- Amgen CEO To Shareholders: I Feel Your Pain, Too
- Amgen's Visit From The "Tooth Fairy" (By Way Of Root Canal?)
- Merck's Layoffs Show Pain Of Lower Drug Sales,Too Many Reps
- Pfizer "Re-Lighting" Chantix Ad Campaign For Smokers?
- Fixing Pfizer And Your Emails
- Former Merck CEO Prodding Industry On Drug Pricing
- Merck "Adapts" To Tredaptive Setback
- Regulatory "Risky Business" for Pharma & Biotech
- Eli Lilly's Ladies' Drug Campaign: Kind of Strange TV Ad?
- Home Prices: Glass Still Seems Half Empty
- Ethanol, Chickens (Headless) And Paula Abdul: Your Emails
- Nissan Says It Will "Plug" Electric Cars In U.S. By 2010
- Buffett's Bond Insurer Sees Business "Skyrocket"
- Coke And Why It Chose Kobe Bryant For Endorsements
- Your First Move For Tuesday May 13th
- Web Extra: A Taste for Chips
- Emerging Money: China
- Pops & Drops: Alcoa, Blockbuster...
- Future Trade: Robotic Surgery
- Home Prices: Glass Still Seems Half Empty
- A Wish List for Fixing Wall Street
- Economy Sluggish, Inflation Higher: Fed Survey
- Bonds Slip on Sales, Import Price Indicators
- Nissan Plans Electric Car in U.S. by ’10
- ECB's Noyer Warns of Explosive Global Inflation Mix
- The iSopranos: Apple to Start Selling HBO Shows
- Retail Sales Show Strength Outside of Auto Sector
- Bernanke: Credit Markets Are Still Facing Difficulty
- Cohen: S&P To Rally Back to 1,500 By Year's End
- Wal-Mart Shares Fall on Weak Earnings Forecast
 |
CNBC.com |
So far, all of the American big pharmas have filed except for Schering-Plough [SGP
Loading...
(%)
] . The figures I'm using are from the "Total Compensation" tables, so everything (base salary, bonuses, stock, etc.) and the kitchen sink are thrown in.
Even though it's kind of a hybrid pharma/medicaldevice/consumer products company and not a
 |
CNBC.com |
] Bill Weldon is king of the hill. His total compensation last year was nearly $32 million, up from $28.5 million in 2006. Recently retired Wyeth [WYE
Loading...
(%)
] chief Bob Essner came in second, despite the fact he took a pay cut during what was a not-so-good year for WYE. He took home $24.1 million, down from $32.8 million the year before. And his successor, Bernard Poussot, pocketed $12.6 million, nearly $2 million less than he got in '06.
Merck's [MRK
Loading...
(%)
] Dick Clark, who talks about the company's recent stock performance and upcoming catalysts in today's Wall Street Journal nearly doubled his compensation. In 2006, Clark made $10.2 million and last year the company paid him nearly $20 million.
Eli Lilly [LLY
Loading...
(%)
] also gave its top-two execs a pay cut last year. Sidney Taurel, who is retiring next week, made $13 million, a more than $2 million drop from 2006. And his successor, COO John Lechleiter, also saw his pay shrink by $2 million to $9.3 million.
After being named the permanent head of Bristol-Myers Squibb [BMY
Loading...
(%)
] , Jim Cornelius got the biggest raise of his peers. He went from nearly $1.5 million in '06 to $11.3 million last year. The company stopped paying for his $25,500 monthly rent plus utilities on his Manhattan apartment last September and revealed it had picked up the tab for $85,000 in private jet fees while Cornelius was interim CEO so he could commute from his home to Bristol HQ in New York.
And then there's Pfizer's [PFE
Loading...
(%)
] Jeff Kindler. His total compensation saw a slight pullback from $9.7 million in 2006 to $9.5 million in '07. But, the board raised his base salary by $150,000 and gave him a bonus last year equal to 212 percent of his base. In dollars, that equates to a $3.1 million bonus, but the board could have given him as much as $4.3 million extra.
Questions? Comments?
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes